Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome activator subunit 2 pseudogene 2 (PSME2P2) is a processed pseudogene of the human *PSME2* gene, which encodes the beta subunit of the PA28 (11S) proteasome activator complex. While the functional *PSME2* gene product plays a role in immunoproteasome assembly and antigen processing, PSME2P2 lacks the capacity to code for a functional protein due to mutations or sequence truncation. Like other pseudogenes, it may have minor regulatory RNA roles, but is not considered a direct molecular target for drug discovery, receptor research, or therapeutic intervention. Clarification of Issues: - PSME2P2 is a **pseudogene**, not a functional gene or protein, and does not serve as a receptor, enzyme, or drug target in any established context. - Information about protein structure, function, and druggability refers to the *parent gene* (*PSME2*), not to the pseudogene PSME2P2 itself. - If the intent was to find information for the canonical, functional protein, refer to "Proteasome activator subunit 2 (PA28 beta)" (PSME2), *not* to PSME2P2. Summary: PSME2P2 is a non-functional DNA sequence derived from a duplication or retrotransposition of the protein-coding *PSME2* gene. It has no established therapeutic, diagnostic, or pharmacological relevance, and should not be considered a canonical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome activator subunit 2 pseudogene 2 (PSME2P2).